VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $171,000 | -86.7% | 28,900 | -79.5% | 0.01% | -92.4% |
Q1 2020 | $1,287,000 | -45.0% | 140,700 | -16.1% | 0.09% | -30.3% |
Q4 2019 | $2,339,000 | +15.7% | 167,700 | +42.7% | 0.13% | +8.2% |
Q3 2019 | $2,022,000 | +81.2% | 117,500 | +186.6% | 0.12% | +79.4% |
Q2 2019 | $1,116,000 | +168.3% | 41,000 | +86.4% | 0.07% | +183.3% |
Q3 2018 | $416,000 | -3.3% | 22,000 | 0.0% | 0.02% | -7.7% |
Q2 2018 | $430,000 | +14.4% | 22,000 | +10.0% | 0.03% | +8.3% |
Q1 2018 | $376,000 | +62.1% | 20,000 | +42.9% | 0.02% | +60.0% |
Q4 2017 | $232,000 | – | 14,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |